Annegrit Seifried

Annegrit Seifried is an experienced professional in the field of protein therapeutics and structural biology, currently serving as Associate Director at Odyssey Therapeutics since December 2021. Previously, Annegrit held various roles at Octapharma Biopharmaceuticals GmbH from January 2016 to December 2021, including Group Manager R&D Analytics and Team Lead in Assay Development. Academic experience includes a lecturer position at Albstadt-Sigmaringen University in 2021, postdoctoral research positions at the Rudolf Virchow Center and Institut Cardiologie de Montréal, and a PhD in Pharmacology from The Julius Maximilians University of Würzburg. Annegrit also holds a Diploma in Biology from Goethe University Frankfurt.